Spinocerebellar Ataxia
16
5
7
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Wearable Gait Sensors
Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias
The Study of Transcranial Magnetic Stimulation in the Regulation of Spinocerebellar Ataxia
Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
Hong Kong Spinocerebellar Ataxias Registry
Laryngeal Adaptation for Speech and Swallowing
Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
The EUROSCA Natural History Study
Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia
Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias
Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial
Neuromuscular Electrical Stimulation on Median Nerve Facilitates Low Motor Cortex Excitability in Human With Spinocerebellar Ataxia
The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias